17-Year-Old Leukemia Patient Receives Immunoglobulin Treatment After Father’s Intervention
A 17-year-old patient diagnosed with leukemia at the Hospital Edgardo Rebagliati of EsSalud in Lima, Peru, received immunoglobulin treatment after his father, Luis Torres, contacted RPP’s Rotafono, according to multiple sources. The patient had been without the medication since June 7, prompting urgent action from health authorities.
Father’s Plea Triggers Medical Response
Luis Torres described his distress over his son’s deteriorating condition due to the immunoglobulin shortage, as reported by RPP. “I was desperate,” he said, emphasizing the risk of complications without timely treatment. After the case was aired on RPP’s Rotafono, EsSalud officials contacted Torres, initiating steps to secure the medication.
EsSalud Confirms Immediate Action
EsSalud confirmed that the patient was admitted to the hospital and received immunoglobulin on the same day, according to a statement released by the institution. “We prioritize patients’ health and address urgent cases promptly,” the statement read. The hospital, located in Jesús María district, is a key facility for specialized care in the region.
Immunoglobulin Therapy in Leukemia Management
Immunoglobulin therapy is commonly used to support patients with weakened immune systems, including those undergoing leukemia treatment. According to the Peruvian Society of Hematology, such interventions are critical in preventing infections during chemotherapy. However, supply chain disruptions have occasionally led to shortages, as highlighted in a 2023 report by the Ministry of Health.
Public Health Concerns Amid Medication Shortages
The incident has reignited debates about medication availability in public health systems. A 2022 study published in *Revista Peruana de Medicina Interna* noted that 15% of hospitals in Peru reported intermittent shortages of essential drugs, including immunoglobulins. EsSalud did not immediately respond to requests for data on current stock levels.
Community Response and Advocacy
Local advocacy groups have praised the swift resolution but stressed the need for systemic solutions. “While this case ended positively, many families face similar challenges daily,” said María Gómez, director of the Peruvian Cancer Association. “Transparency and proactive management are essential.”
What Happens Next?
The patient’s condition remains stable, according to hospital records. Health officials are reviewing procurement processes to prevent future shortages. Meanwhile, Torres expressed gratitude, stating, “We are relieved, but this highlights the fragility of our healthcare system.”
EsSalud Official Website | RPP News | Peruvian Society of Hematology